Biohorizon already has a good share of the market for implants.
Striate is replacing an existing product they sell that has little competitive advantage against other products in the market
Striate will give this advantage so they will be able to increase their market share
Replacing the existing product they sell gives Orthocell orders plus the upside growth
- Forums
- ASX - By Stock
- Ann: First orders for Striate and Remplir
Biohorizon already has a good share of the market for...
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
37.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.49M |
Open | High | Low | Value | Volume |
37.5¢ | 37.5¢ | 37.5¢ | $3.562K | 9.498K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10335 | 37.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.5¢ | 13877 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10335 | 0.375 |
3 | 45040 | 0.370 |
4 | 111880 | 0.365 |
9 | 98737 | 0.360 |
9 | 116254 | 0.355 |
Price($) | Vol. | No. |
---|---|---|
0.385 | 13877 | 2 |
0.390 | 1394 | 2 |
0.395 | 4579 | 1 |
0.400 | 46825 | 6 |
0.405 | 11143 | 1 |
Last trade - 15.36pm 23/07/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online